openPR Logo
Press release

Global Raloxifene Hydrochloride Tablets Market Size | COVID-19 Impact Analysis | Forecast to 2027

02-04-2022 12:56 PM CET | Health & Medicine

Press release from: Orion Market Research

The global raloxifene hydrochloride tablets market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). These tablets are generally recommended as preventative medicine for osteoporosis as well as a treatment medicine for breast cancer. It can also be taken orally for prevention or treatment of bone loss caused by hormone therapy, which occurs due to a lack of estrogen after menopause. Thus, the growing prevalence of breast cancer and osteoporosis especially among older women is anticipated to spur market growth. Further, the properties of raloxifene hydrochloride such as prevention of flashes, vaginal dryness, night sweats, along with the reduction of chances for cardiac arrest & stroke is also largely contributing to the market growth.

To Request a Sample of our Report on Global Raloxifene Hydrochloride Tablets Market: https://www.omrglobal.com/request-sample/raloxifene-hydrochloride-tablets-market

In terms of geography, Europe is anticipated to register substantial growth. The primary factors attributing to this growth include the rising population base suffering from osteoporosis and other bone disorders, growing healthcare expenditure and so on. However, a lack of awareness among rural people will hinder the growth of the global raloxifene hydrochloride market. Although some leading players offer combination therapies along with their products which are expected to propel demand during the next few years.

Market Coverage

· The market number available for – 2020-2027

· Base year- 2020

· Forecast period- 2021-2027

· Segment Covered

· Regions Covered- Globally

· Competitive Landscape: Eli Lilly and Company, InvaGen Pharmaceuticals Inc., and Teva Pharmaceutical Industries Ltd., among others.

(Get 15% Discount on Buying this Report)

A full Report of Global Raloxifene Hydrochloride Tablets Market is Available at: https://www.omrglobal.com/industry-reports/raloxifene-hydrochloride-tablets-market

Global Raloxifene Hydrochloride Tablets Market Report by Segment

By Application

• Osteoporosis

• Breast Cancer

By Distribution Channel

• Hospital Pharmacies

• Retail Pharmacies

• Online Pharmacies

Global Raloxifene Hydrochloride Tablets Market by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

Reasons to buy from us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Raloxifene Hydrochloride Tablets Market Size | COVID-19 Impact Analysis | Forecast to 2027 here

News-ID: 2545418 • Views:

More Releases from Orion Market Research

AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2033
AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2 …
AI-enabled imaging modalities market was valued at approximately USD 1.36 billion, and it is projected to reach around USD 19.78 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 34.67% from 2024 to 2033. AI-Enabled Imaging Modalities Market Overview The AI-enabled imaging modalities market is experiencing rapid growth, driven by advancements in artificial intelligence and machine learning technologies. These innovations are enhancing the capabilities of various imaging modalities, including
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Playe …
Global tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing incidence of cancer and advancements in imaging and tracking technologies. These systems improve the precision of
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry Growths to 2033
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry …
Tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing prevalence of cancer and advancements in imaging technologies. These systems play a crucial role in enhancing the
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and G …
SNP genotyping market was valued at approximately USD 31.66 billion, and it is projected to reach around USD 238.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 20.1% from 2024 to 2034. SNP genotyping Market Overview The SNP genotyping market is experiencing significant growth, driven by advancements in genotyping technologies, an increase in the prevalence of genetic disorders, and the expansion of pharmacogenomics and precision medicine initiatives. This

All 5 Releases


More Releases for Raloxifene

Raloxifene Hydrochloride Market: An Extensive Analysis Predicts Significant Futu …
The Global Raloxifene Hydrochloride Market size is estimated at $2.1 Billion in 2025 and is forecast to register an annual growth rate (CAGR) of 8.8% to reach $4.5 Billion by 2034. The latest study released on the Global Raloxifene Hydrochloride Market by USD Analytics Market evaluates market size, trend, and forecast to 2034. The Raloxifene Hydrochloride market study covers significant research data and proofs to be a handy resource document for
Raloxifene Market Booming Worldwide with Latest Trend and Future Scope by 2029
Raloxifene Market size was valued at USD billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 13.6% from 2024 to 2030. By inhibiting the effects of estrogen on breast tissue, this drug lowers the risk of developing invasive breast cancer. This could halt the progression of cancers that require estrogen to flourish. Raloxifene is available as a tablet that must be swallowed.
Raloxifene Hydrochloride Tablets Market Is Likely to Experience a Tremendous Gro …
Raloxifene Hydrochloride Tablets Market is anticipated to grow at a significant CAGR during the forecast period. These tablets are generally recommended as preventative medicine for osteoporosis as well as a treatment medicine for breast cancer. It can also be taken orally for prevention or treatment of bone loss caused by hormone therapy, which occurs due to a lack of estrogen after menopause. Thus, the growing prevalence of breast cancer and
Raloxifene Market Trends, Size, Share, Opportunities, Regional Outlook, Industry …
DBMR has presented updated research report on 'Raloxifene Market', offering insightful information like market share, market size, and growth rate during the forecast period 2022 - 2029 that are precisely projected based on type, application, sales channel, and region. Healthcare industry can gain great benefits with this market research report which brings market and competitive landscape clearly into the focus and assist to make better decisions. Additionally, the data and
Global Raloxifene Hydrochloride Market
Raloxifene hydrochloride is an oral medication envisioned for the preclusion of osteoporosis in postmenopausal women. In addition, raloxifene hydrochloride medications are also utilized for the deduction of risk and treatment of invasive breast cancer. Raloxifene hydrochloride is sold under the brand name of Evista among all others. Key factors propelling the growth of this market are increment in the number of diseases such as osteoporosis and breast cancer coupled with
Raloxifene Hydrochloride Market Forecast 2021-2028, Latest Trends and Opportunit …
The proposed Raloxifene Hydrochloride Market report will encompass all the qualitative & quantitative aspects including the market size, market estimates, growth rates & forecasts & hence will give you a holistic view of the market. The study also includes detailed analysis of market drivers, restraints, technological advancements & competitive landscape along with various micro & macro factors influencing the market dynamics. Raloxifene is a medication used to treat and prevent osteoporosis